The renal factor in erythropoiesis
Kuratowska, Z.; Kopeć, M.
Acta Physiologica Polonica 22(6): 800-803
1971
ISSN/ISBN: 0044-6033 PMID: 5152815 Document Number: 31588
Document emailed within 1 workday
Related Documents
Filimonov, V.I. 1971: The factor inhibiting erythropoiesis Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 15(5): 57-60Miller, K.L.; Schooley, J.C.; Smith, K.L.; Kullgren, B.; Mahlmann, L.J.; Silverman, P.H. 1989: Inhibition of erythropoiesis by a soluble factor in murine malaria Experimental Hematology 17(4): 379-385
Lye, W.C.; Lee, E.J.; Liu, T.C.; Han, P.; Tan, G.B. 1991: Erythropoietin levels and inhibition of erythropoiesis in end-stage renal failure Annals of the Academy of Medicine Singapore 20(6): 755-757
Zhang, N.; Gong, K.; Yang, X.-Y.; Xin, D.-Q.; Na, Y.-Q. 2006: Expression of hypoxia-inducible factor-1-alpha, hypoxia-inducible factor-2alpha and vascular endothelial growth factor in sporadic clear cell renal cell renal cell carcinoma and their significance in the pathogenesis thereof Zhonghua Yi Xue Za Zhi 86(22): 1526-1529
Yanagisawa, K.; Yano, A.; Takada, K.; Yasukawa, M.; Fujita, S. 1994: Increase of erythropoiesis and thrombopoiesis, and induction of remission by granulocyte colony-stimulating factor (G-CSF) in a patient with hypoplastic leukemia Leukemia 8(7): 1249-1251
Saito, A.; Suzuki, I.; Chung, T.G.; Okamoto, T.; Hotta, T. 1986: Separation of an inhibitor of erythropoiesis in "middle molecules" from hemodialysate from patients with chronic renal failure Clinical Chemistry 32(10): 1938-1941
Peschle, C.; Condorelli, M. 1972: Pure red cell aplasia associated with thymoma. Demonstration of an autoimmune serum factor inhibiting erythropoiesis and remission induced by cyclophosphamide Haematologica 58(9): 553-559
Sheviakov, S.A.; Zakharov, I.M. 2010: Dynamic changes of erythropoietin and tumor necrosis factor-alpha levels in peripheral blood and their correlation with erythropoiesis changes in posttransfusion polycythemia in animals Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 96(11): 1122-1128
Baldus, M.; Walter, H.; Thies, K.; Anders, C.; Stein, M.; Hellstern, P.; Brass, H. 1998: Transferrin receptor assay and zinc protoporphyrin as markers of iron-deficient erythropoiesis in end-stage renal disease patients Clinical Nephrology 49(3): 186-192
Ohno, Y. 1976: Effects of androgens on erythropoiesis. in vivo and in vitro actions of androgens on erythropoiesis Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 39(2): 149-157
Thanakitcharu, P.; Jirajan, B. 2016: Prevalence of Hemoglobin Cycling and its Clinical Impact on Outcomes in Thai End-Stage Renal Disease Patients Treated with Hemodialysis and Erythropoiesis-Stimulating Agent Journal of the Medical Association of Thailand 99(Suppl 2): S28-S37
Tsau, Y.K.; Chen, C.H. 1991: Urinary and renal tissue insulin-like growth factor 1 in compensatory renal hypertrophy Journal of the Formosan Medical Association 90(8): 764-768
Gianello, P.; Squifflet, J.P.; Carlier, M.; Jamart, J.; Pirson, Y.; Mahy, B.; Berbinschi, A.; Donckier, J.; Ketelslegers, J.M.; Lambotte, L. 1989: Evidence that atrial natriuretic factor is the humoral factor by which volume loading or mannitol infusion produces an improved renal function after acute ischemia. An experimental study in dogs Transplantation 48(1): 9-14
Lu, G-yuan.; Shen, L.; Wang, Z-yue.; Guo, X-fang.; Bai, X.; Su, J.; Ruan, C-geng. 2008: Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases Chinese Medical Journal 121(2): 133-136
Osterud, B.; Kasper, C.K.; Lavine, K.K.; Prodanos, C.; Rapaport, S.I. 1981: Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VIi and bovine tissue factor Thrombosis and Haemostasis 45(1): 55-59
Grino, J.M. 1994: BN 52021: a platelet activating factor antagonist for preventing post-transplant renal failure. A double-blind, randomized study. The BN 52021 Study Group in Renal Transplantation Annals of Internal Medicine 121(5): 345-347
Andresen, J.L.; Ehlers, N. 1998: Chemotaxis of human keratocytes is increased by platelet-derived growth factor-BB, epidermal growth factor, transforming growth factor-alpha, acidic fibroblast growth factor, insulin-like growth factor-I, and transforming growth factor-beta Current Eye Research 17(1): 79-87
McLaughlin, P.J.; Aikawa, A.A.; Davies, H.M.; Bakran, A.; Sells, R.A.; Johnson, P.M. 1991: Tumour necrosis factor in renal transplantation Transplantation Proceedings 23(1 Part 2): 1289-1290
Peschle, C.; Condorelli, M. 1972: Relationship between the renal erythropoietic factor and plasma erythropoietin Haematologica 58(9): 535-540
Pedersen, E.B. 1993: Insulin-like growth factor i against chronic renal failure Ugeskrift for Laeger 155(28): 2217